Looking ahead to 2030, our model projects MSM could trade at an average price of $121.88, with a potential range between $91.41 and $152.35. This represents a potential 3.9% return from today's price.
Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine ...
A team of international scientists has made a major leap forward in diabetes research by successfully 3D printing functional human islets using a novel bioink. Presented today at the ESOT Congress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results